183 related articles for article (PubMed ID: 26282004)
1. AdipoRon: a possible drug for colorectal cancer prevention?
Malih S; Najafi R
Tumour Biol; 2015 Sep; 36(9):6673-5. PubMed ID: 26282004
[TBL] [Abstract][Full Text] [Related]
2. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
[TBL] [Abstract][Full Text] [Related]
3. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway.
Sugiyama M; Takahashi H; Hosono K; Endo H; Kato S; Yoneda K; Nozaki Y; Fujita K; Yoneda M; Wada K; Nakagama H; Nakajima A
Int J Oncol; 2009 Feb; 34(2):339-44. PubMed ID: 19148467
[TBL] [Abstract][Full Text] [Related]
5. AdipoRon Protects Against Secondary Brain Injury After Intracerebral Hemorrhage via Alleviating Mitochondrial Dysfunction: Possible Involvement of AdipoR1-AMPK-PGC1α Pathway.
Yu J; Zheng J; Lu J; Sun Z; Wang Z; Zhang J
Neurochem Res; 2019 Jul; 44(7):1678-1689. PubMed ID: 30982205
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
Okada-Iwabu M; Yamauchi T; Iwabu M; Honma T; Hamagami K; Matsuda K; Yamaguchi M; Tanabe H; Kimura-Someya T; Shirouzu M; Ogata H; Tokuyama K; Ueki K; Nagano T; Tanaka A; Yokoyama S; Kadowaki T
Nature; 2013 Nov; 503(7477):493-9. PubMed ID: 24172895
[TBL] [Abstract][Full Text] [Related]
7. Activation of adiponectin receptors has negative impact on muscle mass in C2C12 myotubes and fast-type mouse skeletal muscle.
Ito R; Higa M; Goto A; Aoshima M; Ikuta A; Ohashi K; Yokoyama S; Ohno Y; Egawa T; Miyata H; Goto K
PLoS One; 2018; 13(10):e0205645. PubMed ID: 30308063
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin and adiponectin receptor in relation to colorectal cancer progression.
Byeon JS; Jeong JY; Kim MJ; Lee SM; Nam WH; Myung SJ; Kim JG; Yang SK; Kim JH; Suh DJ
Int J Cancer; 2010 Dec; 127(12):2758-67. PubMed ID: 21351255
[TBL] [Abstract][Full Text] [Related]
9. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
[TBL] [Abstract][Full Text] [Related]
10. [Adiponectin Receptor Agonist AdipoRon Inhibits the Proliferation of Myeloma Cells via the AMPK/Autophagy Pathway].
Wang SJ; Wang C; Wang WQ; Hao QQ; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):171-176. PubMed ID: 32027272
[TBL] [Abstract][Full Text] [Related]
11. Globular adiponectin and its downstream target genes are up-regulated locally in human colorectal tumors: ex vivo and in vitro studies.
Vetvik KK; Sonerud T; Lindeberg M; Lüders T; Størkson RH; Jonsdottir K; Frengen E; Pietiläinen KH; Bukholm I
Metabolism; 2014 May; 63(5):672-81. PubMed ID: 24636346
[TBL] [Abstract][Full Text] [Related]
12. AdipoRon Attenuates Neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway.
Zheng J; Sun Z; Liang F; Xu W; Lu J; Shi L; Shao A; Yu J; Zhang J
Neuroscience; 2019 Aug; 412():116-130. PubMed ID: 31176703
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin receptor agonist AdipoRon attenuates calcification of osteoarthritis chondrocytes by promoting autophagy.
Duan ZX; Tu C; Liu Q; Li SQ; Li YH; Xie P; Li ZH
J Cell Biochem; 2020 Jun; 121(5-6):3333-3344. PubMed ID: 31898335
[TBL] [Abstract][Full Text] [Related]
14. The adiponectin agonist, AdipoRon, inhibits steroidogenesis and cell proliferation in human luteinized granulosa cells.
Grandhaye J; Hmadeh S; Plotton I; Levasseur F; Estienne A; LeGuevel R; Levern Y; Ramé C; Jeanpierre E; Guerif F; Dupont J; Froment P
Mol Cell Endocrinol; 2021 Jan; 520():111080. PubMed ID: 33189865
[TBL] [Abstract][Full Text] [Related]
15. AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
Gu D; Shi Y; Gong Z; Xia T; Ren H; He D; Yang J; Han Y; Zeng C
Clin Exp Nephrol; 2020 Nov; 24(11):989-998. PubMed ID: 32734507
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.
Ramzan AA; Bitler BG; Hicks D; Barner K; Qamar L; Behbakht K; Powell T; Jansson T; Wilson H
Mol Cell Biochem; 2019 Nov; 461(1-2):37-46. PubMed ID: 31292831
[TBL] [Abstract][Full Text] [Related]
17. Globular adiponectin protects human umbilical vein endothelial cells against apoptosis through adiponectin receptor 1/adenosine monophosphate-activated protein kinase pathway.
Zhao HY; Zhao M; Yi TN; Zhang J
Chin Med J (Engl); 2011 Aug; 124(16):2540-7. PubMed ID: 21933602
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.
Sakellariou S; Fragkou P; Levidou G; Gargalionis AN; Piperi C; Dalagiorgou G; Adamopoulos C; Saetta A; Agrogiannis G; Theohari I; Sougioultzis S; Tsioli P; Karavokyros I; Tsavaris N; Kostakis ID; Zizi-Serbetzoglou A; Vandoros GP; Patsouris E; Korkolopoulou P
BMC Cancer; 2016 Mar; 16():174. PubMed ID: 26931562
[TBL] [Abstract][Full Text] [Related]
19. Exploring the logic and conducting a comprehensive evaluation of AdipoRon-based adiponectin replacement therapy against hormone-related cancers-a systematic review.
Laurindo LF; Sosin AF; Lamas CB; de Alvares Goulart R; Dos Santos Haber JF; Detregiachi CRP; Barbalho SM
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2067-2082. PubMed ID: 37864589
[TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice.
Wang Y; Wan Y; Ye G; Wang P; Xue X; Wu G; Ye B
Eur J Pharm Sci; 2016 Oct; 93():123-31. PubMed ID: 27516150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
